These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16013035)

  • 41. Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines.
    de Mesquita ML; de Paula JE; Pessoa C; de Moraes MO; Costa-Lotufo LV; Grougnet R; Michel S; Tillequin F; Espindola LS
    J Ethnopharmacol; 2009 Jun; 123(3):439-45. PubMed ID: 19501276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226.
    Chen CJ; Hsu MH; Huang LJ; Yamori T; Chung JG; Lee FY; Teng CM; Kuo SC
    Biochem Pharmacol; 2008 Jan; 75(2):360-8. PubMed ID: 17880926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents.
    Benassi L; Magnoni C; Giudice S; Bertazzoni G; Costi MP; Rinaldi M; Venturelli A; Coppi A; Rossi T
    Anticancer Res; 2006; 26(5A):3499-504. PubMed ID: 17094473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyrazoline bearing benzimidazoles: search for anticancer agent.
    Shaharyar M; Abdullah MM; Bakht MA; Majeed J
    Eur J Med Chem; 2010 Jan; 45(1):114-9. PubMed ID: 19883957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mining the NCI screening database: explorations of agents involved in cell cycle regulation.
    Wallqvist A; Monks A; Rabow AA; Thanki N; Shoemaker RH; Covell DG
    Prog Cell Cycle Res; 2003; 5():173-9. PubMed ID: 14593711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of 1-(3',4',5'-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent.
    Srivastava V; Negi AS; Kumar JK; Faridi U; Sisodia BS; Darokar MP; Luqman S; Khanuja SP
    Bioorg Med Chem Lett; 2006 Feb; 16(4):911-4. PubMed ID: 16297622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A structural analysis of the differential cytotoxicity of chemicals in the NCI-60 cancer cell lines.
    Chakravarti SK; Klopman G
    Bioorg Med Chem; 2008 Apr; 16(7):4052-63. PubMed ID: 18243714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hollow fibre model in cancer drug screening: the NCI experience.
    Decker S; Hollingshead M; Bonomi CA; Carter JP; Sausville EA
    Eur J Cancer; 2004 Apr; 40(6):821-6. PubMed ID: 15120037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs.
    Allen OR; Knox RJ; McGowan PC
    Dalton Trans; 2008 Oct; (39):5293-5. PubMed ID: 18827935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A quantitative method for measuring the antitumor potency of recombinant human endostatin in vivo.
    Xu YF; Zhu LP; Hu B; Rong ZG; Zhu HW; Xu JM; Wu ZW; Wang JJ; Xu GX
    Eur J Pharmacol; 2007 Jun; 564(1-3):1-6. PubMed ID: 17346697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on NCI in vitro drug screen utilities.
    Holbeck SL
    Eur J Cancer; 2004 Apr; 40(6):785-93. PubMed ID: 15120034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C5-Modified nucleosides exhibiting anticancer activity.
    Lee YS; Park SM; Kim HM; Park SK; Lee K; Lee CW; Kim BH
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4688-91. PubMed ID: 19596579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L
    J Med Chem; 2007 Jul; 50(14):3167-72. PubMed ID: 17559205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonlinear model predictive control for dosing daily anticancer agents using a novel saturating-rate cell-cycle model.
    Florian JA; Eiseman JL; Parker RS
    Comput Biol Med; 2008 Mar; 38(3):339-47. PubMed ID: 18222419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemoinformatic analysis of NCI preclinical tumor data: evaluating compound efficacy from mouse xenograft data, NCI-60 screening data, and compound descriptors.
    Wallqvist A; Huang R; Covell DG
    J Chem Inf Model; 2007; 47(4):1414-27. PubMed ID: 17555311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chiral salicyl diamines: potent anticancer molecules.
    Gao J; Liu YG; Zhou Y; Zingaro RA
    ChemMedChem; 2007 Dec; 2(12):1723-9. PubMed ID: 17943711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
    Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
    J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.